• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK INC ZENITH FLEX AAA ENDOVASCULAR GRAFT BIFURCATED MAIN BODY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK INC ZENITH FLEX AAA ENDOVASCULAR GRAFT BIFURCATED MAIN BODY Back to Search Results
Catalog Number TFFB-28-96-ZT
Device Problem Leak/Splash (1354)
Patient Problem Other (for use when an appropriate patient code cannot be identified) (2200)
Event Date 03/03/2015
Event Type  Injury  
Event Description
The (b)(6) old male pt in the (b)(4) had an endoleak of unk type on (b)(6) 2015 (603 days post-procedure).The pt was treated on (b)(6) 2013 for an aortic aneurysm.The maximum aortic diameter was 56 mm.The proximal neck had a parallel shape with no plaque/thrombus.The left iliac artery had mild tortuosity, mild occlusive disease, and mild calcification.The pt received a main-body device, a left iliac leg, and a right iliac leg.There was no difficulty deploying any of the components.No other procedures were performed and no additional devices were used.A molding balloon was used but no details were provided regarding its use.At the conclusion of the procedure, the devices were patent with no external compression, flow-limiting kinks, endoleaks, or thrombus.On (b)(6) 2013 (74 days post procedure), the pt was seen in follow-up.There had been no change in the size of the aneurysm.Devices were patent with no external compression, flow limiting kinks, thrombus, migration or endoleaks.On (b)(6) 2015 (603 days post procedure), the pt was seen in follow-up.There had been no change in the size of the aneurysm.Devices were patent with no external compression, flow limiting kinks, thrombus or migration.An endoleak of unk type was noted.
 
Manufacturer Narrative
(b)(4).The event is currently under investigation.
 
Manufacturer Narrative
Pt outcome: on (b)(6) 2013 (74 days post procedure), the pt was seen in follow-up, no change in the size of the aneurysm.Devices were patent with no external compression, flow limiting kinks, thrombus, migration or endoleaks.On (b)(6) 2015 (603 days post procedure) , the pt was seen in follow-up.There had been no change in the size of the aneurysm.Devices were patent with no external compression, flow limiting kinks, thrombus, or migration.An endoleak of unknown type was noted.Investigation- evaluation: based on the information provided, a pt in the spiral-z post-market registry underwent initial endovascular aortic repair (evar) in 2013 with placement of a main body graft and two spiral-z leg extension grafts.At 603 days post-implant, an endoleak of unknown type was observed.No intervention or adverse effect have been reported.The device has completed design control requirements demonstrating that the device meets the predetermined requirements and that the requirements meet the needs of the user.Specifically, these devices have been evaluated in clinical trials which assessed the occurrence of the endoleak.Design verification included radial force testing, migration resistance testing, and water permeability testing.The instructions for use pamphlet (ifu) provides the suggested instructions for use, warnings, and precautions for this device.Specifically, it states "additional endovascular interventions or conversion to standard open surgical repair following initial endovascular repair should be considered for pts experiencing an enlarging aneurysm, unacceptable decrease in fixation length (vessel and component overlap) and/or endoleak.An increase in aneurysm size and/or persistent endoleak or migration may lead to aneurysm rupture." the ifu also provides instructions on "key anatomical elements that may affect successful exclusion of the aneurysm." summary of investigation: limited information was provided regarding this complaint.No lot number, pt imaging, or pt anatomical factor information were provided.Without additional information, a definitive root cause cannot be established.The appropriate internal personnel have been notified and continued monitoring for similar events will be occur.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ZENITH FLEX AAA ENDOVASCULAR GRAFT BIFURCATED MAIN BODY
Manufacturer (Section D)
COOK INC
bloomington IN 47404
Manufacturer Contact
larry pool, mgr
750 daniels way
bloomington, IN 47404
8123392235
MDR Report Key4774948
MDR Text Key5777934
Report Number1820334-2015-00256
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
P020018
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,User Facility
Reporter Occupation Physician
Type of Report Initial
Report Date 04/16/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberTFFB-28-96-ZT
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Distributor Facility Aware Date03/03/2015
Event Location Hospital
Initial Date Manufacturer Received 04/20/2015
Initial Date FDA Received05/12/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age80 YR
-
-